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ARTICLE
Red blood cell mannoses as phagocytic ligands
mediating both sickle cell anaemia and malaria
resistance
Huan Cao1, Aristotelis Antonopoulos 2, Sadie Henderson3, Heather Wassall1, John Brewin4, Alanna Masson5,
Jenna Shepherd1, Gabriela Konieczny1, Bhinal Patel2, Maria-Louise Williams1, Adam Davie 1,
Megan A. Forrester1, Lindsay Hall1, Beverley Minter1, Dimitris Tampakis6, Michael Moss3, Charlotte Lennon1,
Wendy Pickford1, Lars Erwig1, Beverley Robertson2, Anne Dell4, Gordon D. Brown 1,7, Heather M. Wilson 1,
David C. Rees4, Stuart M. Haslam 2, J. Alexandra Rowe 8✉, Robert N. Barker1,9 & Mark A. Vickers 1,3,5,9✉
In both sickle cell disease and malaria, red blood cells (RBCs) are phagocytosed in the spleen,
but receptor-ligand pairs mediating uptake have not been identified. Here, we report that
patches of high mannose N-glycans (Man5-9GlcNAc2), expressed on diseased or oxidized
RBC surfaces, bind the mannose receptor (CD206) on phagocytes to mediate clearance. We
find that extravascular hemolysis in sickle cell disease correlates with high mannose glycan
levels on RBCs. Furthermore, Plasmodium falciparum-infected RBCs expose surface mannose
N-glycans, which occur at significantly higher levels on infected RBCs from sickle cell trait
subjects compared to those lacking hemoglobin S. The glycans are associated with high
molecular weight complexes and protease-resistant, lower molecular weight fragments
containing spectrin. Recognition of surface N-linked high mannose glycans as a response to
cellular stress is a molecular mechanism common to both the pathogenesis of sickle cell
disease and resistance to severe malaria in sickle cell trait.
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S ickle cell disease comprises a group of disorders affectingover 20 million individuals and is caused by a mutationcausing an amino acid substitution (E6V) in the adult
hemoglobin β chain,1,2 so that the physiological hemoglobin (Hb)
A tetramer, α2β2, is replaced by the HbS tetramer α2βS2, which
can form pathological polymers. Homozygosity for wild type and
sickle cell alleles are referred to hereafter as HbAA and HbSS
respectively. The disease is variable, with modifiers such as high
levels of the fetal β hemoglobin chain, γ, resulting in α2γ2 or α2
βSγ tetramers that terminate HbS polymers and ameliorate dis-
ease. The milder disease is also associated with compound het-
erozygosity of the sickle cell allele with quantitative defects in α or
β chains (thalassemias) or other hemoglobin chain variants like
hemoglobin C (HbC).
Sickle cell disease is characterized by multi-system vasculo-
pathy and hemolysis, which cause much morbidity and mortality,
especially in Africa. The anemia has been ascribed to abnormal
physical properties of diseased red blood cells (RBCs), which
interfere with their transit through the splenic and hepatic vas-
culatures, so stimulating phagocytic uptake by tissue macro-
phages.3 However, the observation that isolated macrophages take
up HbSS RBCs selectively in vitro4 indicates the presence of
disease-specific ligands, which remain uncharacterized. Hetero-
zygosity for HbS, sickle cell trait, affects over 250 million indi-
viduals and is maintained in the population by conferring
protection against severe malaria. Individuals with sickle cell
traits contain a mixture of hemoglobins referred to hereafter as
HbAS. The mechanism underlying this protection is not fully
explained, but the mutation has long been known to prevent high
levels of parasitemia.5,6 Yet under most conditions in vitro, the
parasites grow equally well in HbSS RBCs compared to those with
normal hemoglobin,7,8 implying that protection is due to efficient
immune clearance of infected HbSS RBCs, and again raising
questions as to the identity of the ligands responsible for med-
iating phagocytosis. Here we show that oxidative stress induces
RBCs to express high levels of surface high mannose glycans and
this mechanism is active in both sickle cell disease and after
infection by P. falciparum, especially in RBCs with sickle cell trait.
The high mannose glycans can be recognized by the mannose
receptor (CD206) expressed on macrophages and Lyve-1+
endothelial cells in the spleen to effect phagocytosis. High man-
nose glycans, therefore, act as damage-associated and pathogen-
associated molecular patterns and are important in mediating
both beneficial and pathological effects of the sickle cell allele.
Results
Red blood cells from patients with sickle cell disease express
high mannose N-glycans on their surfaces. We postulated these
putative uptake ligands might be N-linked glycans, given the
prominence of the glycocalyx on RBCs and the corresponding
expression of lectins as key innate receptors on macrophages.9 A
survey for surface ligands using a panel of plant lectins identified
two panel members that bound preferentially to HbSS RBC
(Fig. 1a), Galanthus nivalis Agglutinin (GNA) and Narcissus
pseudonarcissus Lectin (NPL). The binding was specific (Sup-
plementary Table 1, Supplementary Figs. 1a–b, 2a) and both
lectins were noted to have similar specificities for terminal
mannose residues (Supplementary Fig. 1a).10,11 Microscopy with
fluorescent GNA lectin revealed discrete patches on the surfaces
of HbSS, but not healthy (HbAA), RBCs (Fig. 1b, Supplementary
Fig. 1c, d). Glycomic analysis using mass spectrometry showed
that HbSS RBCs express N-linked high mannose glycans, here-
after high mannose glycans (Man5-9GlcNAc2; Fig. 1c), which are
known ligands for phagocytosis by macrophages9,12 and therefore
good candidates for mediating RBC uptake. High mannose
glycans are also observed in the N-glycome profiles from HbAA
RBC ghosts (Fig. 1c, Supplementary Fig. 3, Supplementary File 1).
The proportions of high mannose glycans with respect to whole
N-glycomes were not significantly different between sickle and
healthy RBC ghosts (Supplementary Fig. 1e). The marked dif-
ference between GNA binding on the cell surface of HbAA
compared to HbSS RBCs is therefore not explained by the total
high mannose glycan content of the ghosts.
RBC surface mannose correlates with extravascular hemolysis
in sickle cell disease. To assess the relevance of high mannose N-
glycan display for RBC uptake in vivo, we exploited the hetero-
geneity of sickle cell disease arising from the interactions of HbS
with other mutations in the globin loci (such as HbC, α-tha-
lassemias, and β-thalassemias) that also protect against malaria.13
If mannoses were phagocytic ligands in sickle cell disease, higher
levels of mannose exposure should correlate with more severe
anemia. Despite a similar glycomic profile, RBCs from patients
who were homozygous for HbS tended to exhibit higher binding
of GNA lectin, compared to RBCs from healthy individuals
containing HbAA or those with sickle cell trait (HbAS) (Fig. 2a).
Patients with sickle cell disease who were compound hetero-
zygotes for HbS and either HbC or β-thalassemia, or who had
HbSS but with mitigating α-thalassemia or high levels of fetal
hemoglobin (HbF), tended to exhibit low to intermediate GNA
lectin binding (Fig. 2a). RBCs in other anemias did not express
high levels of exposed mannose residues (Supplementary Fig. 2a).
The classical apoptotic marker for phagocytosis, phosphati-
dylserine, as measured by annexin V binding, was expressed at
similar, low levels on RBCs from each of the clinical groups
(Supplementary Fig. 2b), although it was highly expressed on
positive control calcium ionophore treated, eryptotic RBCs
(Supplementary Fig. 2c). Overall, GNA lectin binding correlated
significantly with more severe anemia (Fig. 2b) and other markers
of hemolysis (Supplementary Fig. 2d, e), consistent with high
mannose N-glycan expression driving extravascular uptake by
hepatosplenic phagocytes, which is the major mechanism of
hemolysis in sickle cell disease.14 A minor, but significant, the
proportion of RBC loss in sickle cell disease is also accounted for
by intravascular hemolysis.14 However, plasma lactate dehy-
drogenase (LDH) levels, a marker of intravascular hemolysis,14
did not correlate with RBC GNA lectin binding (Fig. 2c, d, e)
within HbSS patients. We postulated that mannose-binding lectin
might bind and opsonize sickle cells, but no significant correla-
tions between levels of this plasma protein and hemolytic phe-
notypes were observed (Supplementary Fig. 4a–c). Furthermore,
when we added cells washed free of plasma to macrophages, SS,
but not AA, RBCs were selectively taken up and this could be
inhibited by mannan (Fig. 2f), indicating the macrophages
expressed a receptor that interacted directly with surface
mannoses.
Surface mannoses can be induced on healthy RBC by oxidative
stress and are recognized by the mannose receptor (CD206).
High mannose N-glycans (Man5-9GlcNAc2) were detected in
glycomic analyses of healthy (HbAA) RBCs (Fig. 1c, Supple-
mentary Fig. 3). Furthermore, permeabilization of healthy RBCs
allowed GNA lectin binding in patches that colocalized with the
membrane skeleton (Supplementary Fig. 5a). Sickle cell disease is
associated with intracellular oxidative stress,15,16 so we deter-
mined whether exposing healthy RBCs to an oxidizing agent
(Supplementary Fig. 5b) would alter the surface mannose expo-
sure as assessed by GNA lectin binding (Fig. 3a). Under the
experimental conditions applied, oxidation of healthy RBCs
indeed resulted in binding of GNA lectin, with similar, but fewer,
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Fig. 1 HbSS RBCs are characterized by microdomain expression of surface mannoses. Whole blood flow cytometry analysis of HbAA (normal
hemoglobin) and HbSS (homozygous sickle cell hemoglobin) RBCs using fluorescently labeled plant lectins, detailed in “Methods” section. Vertical axes
show normalized geometric mean fluorescence (gMFI). Symbols of terminal carbohydrates detected by plant lectins are indicated. Data shown as median
+/− IQR, n= 7 per group for significant differences, 2 tailed Mann-Whitney p values shown, distinct samples measured once each, 3 separate
experiments. Annotation uses conventional symbols for carbohydrates in accordance with http://www.functionalglycomics.org guidelines: purple diamond,
sialic acids; yellow circle, galactose; blue square, N-acetyl glucosamine; green circle, mannose; red triangle, fucose. a Galanthus nivalis Agglutinin (GNA)
lectin staining (red) of HbSS and HbAA RBCs, immunofluorescence, merged with the bright field. b MALDI-ToF mass spectra (m/z versus relative
intensity) for glycomic analysis of N-glycans from membrane ghosts from individual HbSS and HbAA donors. Red boxes indicate high mannose structures.
Annotation uses conventional symbols for carbohydrates in accordance with http://www.functionalglycomics.org guidelines: purple diamond, sialic acids;
yellow circle, galactose; blue square, N-acetyl glucosamine; green circle, mannose; red triangle, fucose. Only major structures are annotated for clarity. Full
spectra from both HbSS and HbAA donors are shown in Supplementary Fig. 3c.
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patches observed compared to unoxidized HbSS RBCs (Fig. 3b).
Artifactual GNA lectin-binding resulting from permeabilization
of the cell by oxidative damage was ruled out (Supplementary
Fig. 5c), as was potential intracellular O-GlcNAc binding by GNA
lectin (Supplementary Fig. 5d). To identify the cognate receptor
on macrophages, we measured the binding of a panel of recom-
binant mammalian C-type lectin fusion proteins with different
glycan specificities to oxidized RBCs. This survey implicated the
mannose receptor17,18 (MR, CD206), in particular the mannose
recognizing carbohydrate recognition domain (MR-CRD)
(Fig. 3c). We also observed that in cultures of oxidized RBCs with
human monocyte-derived macrophages (HMDM) in vitro,
uptake was restricted to MR positive cells (Fig. 3d). Furthermore,
siRNA knockdown of MR in macrophages (Supplementary
Fig. 6c) specifically reduced phagocytosis (Fig. 3e, Supplementary
Fig. 6d); and phagocytosis was also inhibited by the competing
glycans mannan or chitin, each known to block MR-CRD,19 but
not inhibited by the control glycan laminarin (Fig. 3f, Supple-
mentary Fig. 6e). Finally, MR-CRD-blocking antibody also
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RBC (Fig. 3g, h), which was also sensitive to mannan and chitin
(Fig. 3i). Taken together, these results demonstrate that phago-
cytosis of mannose-displaying RBC is dependent on MR,
although the involvement of other receptors cannot be excluded.
GNA lectin binding proteins comigrate with spectrin con-
taining complexes. The above data show that high mannose
sugars occur in the glycomes of both HbAA and HbSS RBC and
that these sugars can be detected on the surface of HbSS RBC and
oxidized HbAA RBC by GNA lectin binding. To identify the
proteins carrying the high mannose sugars, extracts of HbAA and
HbSS RBC membranes were analyzed by western blots probed
with GNA lectin. A GNA-binding doublet around 260 kDa was
identified in both HbAA and HbSS RBC (Fig. 4a), which is
similar in molecular weight to the abundant membrane skeleton
proteins α-spectrin and β-spectrin. Blots of HbSS ghosts showed
additional GNA lectin-binding bands at ~160 kDa, ~100 kDa,
~70 kDa, and ~50 kDa, which were not seen in fresh HbAA and
HbAS RBC (Fig. 4a-b). When HbAA RBCs were stored for six
weeks, to allow oxidative damage to membrane skeletal pro-
teins,20 lower molecular weight Endo-H (N-glycan specific gly-
cosidase) sensitive GNA lectin-binding bands corresponding in
size to fragments seen in HbSS cells were seen on western blot-
ting, and GNA lectin precipitation enriched these fragments
(Supplementary Fig. 7a, b). The intensity of the 100 kDa fragment
was noted to correlate positively with RBC surface GNA lectin
binding assessed by flow cytometry (Fig. 4b, Supplementary
Fig. 7c), suggesting a role in the surface exposure of high mannose
glycans. The specificity of the GNA lectin binding was confirmed
by treating RBC ghosts with N-glycan specific glycosidases
(PNGase F and Endo-H) prior to western blotting, which abol-
ished GNA-binding to all of the above bands (Fig. 4c). We next
attempted to determine whether treatment of RBC ghosts with N-
glycanases reduced the sizes of GNA-binding bands. A molecular
weight change was not reproducibly observable for the high
molecular weight doublet around 260 kDa, although the large
sizes of these proteins made minor shifts difficult to observe.
However, a ~70 kDa band from HbSS ghosts did show an
appropriate reduction in molecular weight, consistent with clea-
vage of N-glycans after treatment of RBC ghosts with PNGase F
and Endo-H (Fig. 4d). Western blotting with antibodies to β-
spectrin indicated the band contained an epitope derived from
spectrin.
To investigate the association of spectrin with high mannose
glycans species further, we carried out mass spectrometric
analysis of tryptic peptides from the 260 kDa GNA-binding
doublet from both HbAA and HbSS RBC ghosts and found that
both bands contained large quantities of α-spectrin and β-
spectrin (Supplementary Table 2). As has been previously
reported in RBC proteomic experiments,21 other abundant RBC
proteins of lower molecular weight were also identified, including
integral membrane glycoproteins such as Band 3 and Glut-1
(Supplementary Table 2). However, despite extensive mass
spectrometric analyses from the 260 kDa doublet, no conven-
tionally glycosylated peptides were identified.
Further evidence indicating covalent linkages between high
mannose glycan containing glycoproteins/glycopeptides and
spectrin derived peptides came from western blots of membrane
extracts from HbSS RBC or HbAA ghosts treated with trypsin,
which exhibited anti-spectrin binding lower molecular weight
bands comigrating with GNA lectin signals (Supplementary
Fig. 7c, d), particularly marked for the 50 kDa GNA-binding band
and α-spectrin antibodies. GNA lectin precipitation of extracts
from HbAA ghosts followed by western blotting with antibodies
to spectrin detected a ~260 kDa protein (Fig. 4e). Finally, super-
resolution imaging of permeabilized HbAA and HbSS RBC
demonstrated GNA lectin co-localizing with spectrin in discrete
patches scattered in the spectrin membrane skeletal network
(Fig. 4f). Taken together these data support the hypothesis that
spectrin-containing complexes in HbSS and oxidized HbAA
RBCs are N-glycosylated with high mannose glycans, although it
was not possible to detect specific N-glycosylated peptides
through conventional glycoproteomic approaches.
GNA lectin binds to low molecular weight complexes that
include spectrin, exhibit protease resistance, and derive from
higher molecular weight aggregates. In order to generate smaller
fragments of high mannose-bearing fragments that would be
more amenable to characterization, HbSS ghosts were incubated
with serial dilutions of trypsin, spectrin was purified from them,
and then probed with GNA in western blots. This showed that
high concentrations of trypsin, sufficient to digest the 260 kDa
and 160 kDa GNA lectin binding proteins, failed to degrade the
~50 kDa, ~70 kDa, and ~100 kDa GNA lectin binding gel bands
(Fig. 4g and Supplementary Fig. 7e)). Indeed, the intensities of
these bands, particularly that at ~100 kDa, increased with higher
trypsin concentrations (Fig. 4g). Prolonged, high concentration
trypsin digestion eventually degraded the ~100 kDa fragment,
and, to some extent, the ~70 kDa GNA lectin binding bands, with
the concurrent appearance of a new GNA lectin binding band
around 40 kDa, which we term F40 (Supplementary Fig. 7f). This
same pattern of loss of the ~100 kDa and ~70 kDa GNA lectin
binding fragments with the concurrent appearance of F40 was
also observed when HbSS erythrocytes were stored over five
weeks (Supplementary Fig. 7g). Hence, protease digestion results
in the formation of a 40 kDa protease-resistant fragment that
binds GNA lectin and therefore carries high mannose glycans.
Fig. 2 Mannose expression correlates with clinical anemia in sickle cell disease. a Normalized geometric mean fluorescence (gMFI) of Galanthus nivalis
Agglutinin (GNA) lectin staining of RBCs from peripheral blood samples, comparing RBC from patients with sub-types of sickle cell disease (milder
phenotypes: HbSC (compound heterozygotes for hemoglobin S with C) (n= 34), HbS/beta-thal (n= 8)(compound heterozygotes for hemoglobin S with
β-thalassemia), HbSS microcytic (n= 12))(compound heterozygotes for hemoglobin S homozygosity with α-thalassemia) and HbSS HPFH (n= 3))
(compound heterozygotes for hemoglobin S homozygosity with hereditary persistence of fetal hemoglobin) versus healthy donors (n= 45), sickle cell trait
(n= 57)(HbAS) and β-thalassemia (n= 6). The dotted line indicates the 90th centile of GNA lectin binding within healthy samples. Data are shown as
median+/− IQR, 2 tailed Mann–Whitney, p values shown, numerous (>20) experiments. 2 tailed p values relative to HbSS: HbAA, p= 3.9 × 10−14, HbAS,
p= 3.9 × 10−16, HbSC, p= 1.8 × 10−6. Each data point derived from an independent RBC donor. No adjustments made for multiple comparisons. b Plot of
RBC count against normalized GNA gMFI for sickle cell disease: HbS/B+ and HbSC indicates compound heterozygosity for HbS with β-thalassemia and
HbC respectively; Spearman’s rank correlation, p= 7.0 × 10−23, numerous (>20) experiments. Plots of: (c) RBC count versus serum lactate dehydrogenase
(LDH), Spearman’s rank, d) RBC count vs GNA binding, Spearman’s rank, (p= 5.2 × 10−9) e LDH vs. GNA lectin binding; HbSS RBCs for which
corresponding serum LDH values were available; Spearman’s rank correlation, numerous (>20) experiments. f Percentage phagocytosis of HbAA and
HbSS RBCs by human monocyte-derived macrophages analyzed by microscopy. Mannan inhibition as shown. n= 4–7 independent RBC donors over two
independent experiments. Data are shown as median+/− IQR, 2 tailed Mann–Whitney.
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The F40 fragment was concentrated through sequential
100 kDa and 10 kDa cut-off concentrators (Supplementary
Fig. 8a, b), and the resulting band cut out from a gel for
glycoproteomic analysis. Proteomic analysis of F40 identified
peptides from α-spectrin, particularly the N-terminal 370
amino acids (Fig. 4h, Supplementary Table 3). PNGase-F
treatment of the purified F40 fragment released N-glycans
consisting mainly of high mannoses (Man6-Man9) and complex
structures (Supplementary Fig. 8c). However, once again, no
specific glycopeptides could be identified. We postulated that
the reason for this, and the relatively low identified protein
sequence coverage, could be unconventional peptide structures
arising from oxidized and glycated aggregates. Indeed, mass
spectrometry confirmed the presence of lysine glycation in α-
spectrin peptides from F40 at amino acids K59, K270, and
K281. Furthermore, although GNA lectin binding to F40 was
Endo-H sensitive, the enzyme required denaturing conditions
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aggregates. In addition, the N-terminal α-spectrin antibody,
B12, failed to bind to the full-length F40 band, but bound to
smaller fragments after treatment with a combination of
proteases, indicating a cryptic epitope (Supplementary Fig. 8d,
e, f). Finally, when visualized in 3D-SIM, some HbSS cells show
large aggregates of intracellular spectrin, which correspond to
dense GNA lectin surface staining (Fig. 4j). Overall, our data
demonstrate the existence of high mannose glycans in HbSS
RBC extracts and suggest that the main GNA lectin-binding
molecules are spectrin-containing glycoprotein complexes with
atypical structures, including glycated forms, that make analysis
by conventional glycoproteomics challenging.
Infection of RBCs with P. falciparum causes exposure of high
mannose N-glycans, especially those from donors with sickle
cell trait. As infection of RBC with malarial parasites is asso-
ciated with oxidative stress,22 we investigated whether exposure
to high mannose N-glycans might be important in protection
against infection with P. falciparum, particularly in the context
of sickle cell trait. First, we determined the sensitivity of HbAS
RBCs to given oxidative stress and found they bound more
GNA lectin than HbAA RBC (Fig. 5a). Interestingly, the pro-
portion of HbS correlated well with the degree of oxidative
stress (Fig. 5b). These data suggested that exposure to high
mannose N-glycans might contribute to the resistance of
individuals with sickle cell trait to severe malaria, by enhancing
the clearance of infected cells. We, therefore, infected HbAA
and HbAS RBC with P. falciparum and assessed high mannose
N-glycan exposure as the infection progressed through ring,
trophozoite, and schizont stages. HbAA RBCs containing
schizonts, but not trophozoites, expressed significantly higher
exposed high mannose N-glycans as indicated by increased
GNA lectin binding (Fig. 5c). Importantly, HbAS RBCs con-
taining schizonts expressed even higher levels of exposed high
mannose N-glycans, and this increased expression extended
into the trophozoite stages (Fig. 5c). P. falciparum infected
RBCs cytoadhere to vascular endothelium, to avoid phagocy-
tosis by hepatosplenic macrophages,23,24 and this adhesion is
mediated by the expression of PfEMP1 on late-stage infected
RBC.25 Reduced display of PfEMP1 on the surface of HbAS-
infected RBCs is a potential mechanism of protection against
malaria in sickle cell trait,26 and PfEMP1 levels show con-
siderable variation in different HbAS donors.27 We, therefore,
determined PfEMP1 expression in addition to mannose display
and noted a marked inverse correlation (Fig. 5d).
Discussion
This work has identified a receptor-ligand pair mediating RBC
clearance that underlies both the extravascular hemolysis of
sickle cell disease and clearance of P. falciparum infected RBCs.
Immunologically, the latter can be regarded as protective
immunity arising from the recognition of altered self, with the
mannose receptor recognizing a pattern common to both dis-
eased and infected cells. The display of high mannose N-glycans
on membrane proteins could also be regarded as a pathogen-
associated/damage-associated molecular pattern (P/DAMP).
The mannose receptor is expressed in human spleens by Lyve-1
+ cells lining venous sinuses, where they form a physical bar-
rier for blood cells to exit the red pulp and so are ideally located
to perform a filtering function.28 In infection with P. falci-
parum, the parasite evades passage through the spleen by
expressing adhesive proteins, notably PfEMP1, on the surface of
infected RBCs, so that they adhere to endothelial cells in the
systemic circulation. The inverse correlation between mannose
exposure and surface PfEMP1 implies similar processes invol-
ving oxidation-induced membrane skeletal rearrangements
underlie both phenomena.29,30 Reduced PfEMP1 in infected
HbAS RBCs will lead to a failure of cytoadherence, and the
exposed high mannose N-glycans on circulating infected RBC
will induce clearance by hepatosplenic phagocytes. Together
with the spleen’s role in processing high mannose N-glycan
bearing RBCs in sickle cell disease, these data are consistent
with the spleen being the primary organ in removing RBCs
infected with malaria exposing high mannose N-glycans. Our
work also potentially sheds light on the reasons why those with
sickle cell disease are so susceptible to infections with encap-
sulated bacteria, especially Streptococcus pneumoniae, which is
the commonest cause of death in children.1 Capsular poly-
saccharide from pneumococcus is known to bind the
carbohydrate-binding domains of the mannose receptor.31 It,
therefore, seems likely that the high mannose N-glycans on the
surfaces of sickle cells would compete with bacteria for uptake
by the mannose receptor.
Our work has also identified a phenomenon whereby com-
plexes of membrane skeletal proteins, and fragments derived
from them, are associated with high mannose N-glycans, which
act as an eat-me signal. There are still only two accepted eat-me
signals in higher eukaryotes, phosphatidylserine, and calreticu-
lin.32 This work, therefore, adds a third ligand to perform this
role. The expression of ligands for uptake attached to the mem-
brane skeleton would allow receptors on phagocytic cells to bind
to molecules with high tensile strength, which may be important
Fig. 3 Display of membrane skeleton-associated mannose patches is induced by oxidative stress and recognized by the mannose receptor on
macrophages. a Peanut agglutinin (PNA) and Galanthus nivalis Agglutinin (GNA) lectin binding to normal hemoglobin (HbAA) RBCs with or without
oxidation. Mannan blockade for GNA lectin binding shown in blue. 2 tailed Wilcoxon, paired data, PNA, n= 7; GNA, n= 8 biologically independent RBC
donors over two independent experiments. b Immunofluorescence microscopy of GNA lectin/streptavidin (red) staining of healthy HbAA RBCs (above)
and after the oxidative insult (below). c Normalized geometric mean fluorescence (gMFI) for binding analyzed by flow cytometry of murine Fc fusions with
C-type lectins or sub-domains applied to oxidized versus undamaged RBCs. Mannan blockade of mannose receptor-carbohydrate recognition domain (MR-
CRD) binding is shown in blue. MAH, macrophage antigen H. MR-CR, mannose receptor cysteine-rich domain. 2 tailed Wilcoxon, paired data, n= 7
biologically independent RBC donors over two independent experiments. d Immunofluorescence microscopy image of human monocyte-derived
macrophages (HMDM) stained with DAPI (blue) and for mannose receptor (green) after incubation with oxidized HbAA RBCs, shown in magenta.
e Percentage phagocytosis of oxidized RBCs by HMDM treated with human MR specific or scrambled siRNA. 2 tailed Mann–Whitney, n= 4 biologically
independent RBC donors over two independent experiments. f Percentage phagocytosis of healthy or oxidized HbAA RBCs by HMDM with or without pre-
blocking by mannan, chitin, or laminarin, 2 tailed Mann–Whitney, n= 4–8 biologically independent RBC donors over two independent experiments. No
adjustments made for multiple comparisons. g As f but oxidized RBCs are blocked by MR-CRD blocking antibody 15.2 as indicated. 2 tailed Mann–Whitney,
n= 6 biologically independent RBC donors over two independent experiments. h Percentage phagocytosis of sickle cell homozygote (HbSS) RBCs with or
without pre-blocking by MR-CRD blocking antibody 15.2. 2 tailed Mann–Whitney, n= 5 biologically independent RBC donors over three independent
experiments. i HbAA unblocked and HbSS unblocked or mannan and chitin blockade phagocytosis experiments as shown. 2 tailed Mann–Whitney, n= 4-7
biologically independent RBC donors. No adjustments made for multiple comparisons. All data are shown as median+/− IQR.
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for capturing cells as they transit through the spleen under
conditions of high shear stress.
Protein aggregates are thought to form after attacks by free
radicals, reactive oxygen and nitrogen species, and glycation.
These result in a wide variety of amino acid adducts,33 some of
which mediate the cross-links thought to underlie the formation
of aggregates. Complexes of damaged proteins, including spec-
trin, secondary to oxidative damage associated with hemolysis
have long been recognized in RBCs,34–37 partly arising from
interaction with free radicals generated by denatured hemoglobin
species (hemichromes), including in sickle cell disease.38 Oxida-
tive degradation has been shown to be one of the main causes of
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membrane skeletal protein alterations occurring in RBCs in sto-
rage, with proteolytic cleavage having a secondary role.20 Inter-
estingly, spectrin-containing species were detected either as low
molecular weight fragments covering the N-terminus, as found in
our proteomic analysis, or as high molecular aggregates.20 Oxi-
dation during the storage period of RBCs has also been shown to
inactivate glyceraldehyde 3-phosphate dehydrogenase, an
important enzyme for ATP synthesis.20,39 In turn, this leads to
dissociation of spectrin from the phosphatidylserine molecules of
the RBCs membrane, in an ATP dependent mechanism, resulting
in increased spectrin-glycation products.40
Therefore, either by directly acting on the cytoskeletal proteins,
or indirectly through ATP-dependent mechanisms, oxidative
damage of RBCs is a mechanism that induces alterations in
membrane protein organization leading to aggregation of mem-
brane glycoproteins. This is in accordance with a recent report
demonstrating that oxidative stress results in cluster-like struc-
tures on the membrane of RBCs as a result of possible reorga-
nization and aggregation.41 RBCs contain various glycoproteins
such as band 3, glycophorin, GLUT1, CD44, and CD47.42
Therefore, the enhanced phagocytosis we describe could poten-
tially be driven by the aggregation of RBC membrane glycopro-
teins increasing the local concentration of high mannose N-
glycans, thus favoring their recognition by the mannose receptor.
This is in accordance with previous reports showing that the
binding affinity of the mannose receptor increases with the
density of mannose-containing glycoproteins.43 Taken together,
we suggest that oxidative stress in RBCs induces glycoprotein
reorganization and aggregation, resulting in increased high
mannose glycan bearing densities that are recognized by the
mannose receptor.
In summary, we describe a mechanism whereby oxidatively-
damaged, membrane protein complexes display high mannose N-
glycans, which act as eat me signals important in the hemolysis of
sickle cell disease and resistance against severe malaria. It,
therefore, represents a unified mechanism to explain both
advantageous and deleterious consequences of the sickle
mutation.
Methods
Donors. Ethical approval was obtained for the study (North of Scotland REC
Number 11/NS/0026) and any blood obtained using this approval was collected
after informed consent. Further samples, including donors with sickle cell trait,
were obtained from the NHS Grampian Biorepository scheme (application number
TR000142), which provided anonymized samples from routinely collected clinical
samples once all requested tests had been completed and tubes were ready for
disposal. No extra blood samples were taken for research purposes in this scheme.
Anonymized samples were also obtained from patients with sickle cell disease from
King’s College Hospital, where samples were used from routinely collected clinical
samples once all requested tests had been completed. No extra blood samples were
taken for research purposes. Patients were informed that discarded, anonymized
samples might be used for research by displaying a written notice. Hemoglobin
contents were assessed by HPLC (Tosoh G7). All samples from patients were
collected into EDTA tubes (Becton-Dickinson).
RBC isolation. Blood was collected into acid citrate dextrose solution tubes (ACD;
455055, Grenier) and RBC isolated by sodium metrizoate density gradient cen-
trifugation (1.077 g/ml, Lymphoprep; 1114547 Axis-Shield). Packed RBC was
diluted with an equal volume of Dulbecco’s modified Eagle’s medium (DMEM;
4.5 g/L glucose, L-glutamine; 41965, Gibco), stored in ACD (9 ml RBC/DMEM per
ACD tube) at 4 °C and used within 3 days unless otherwise stated.
Lectins. Biotinylated lectins were all purchased from Vector Laboratories. They
include: Galanthus nivalis Agglutinin (GNA, B-1245, 4 μg/ml), Narcissus pseudo-
narcissus Lectin (NPL, B-1375, 4 μg/ml), Griffonia simplicifolia Lectin II (G.Simp,
B-1215, 4 μg/ml), Solanum tuberosum Lectin (STL, B-1165, 20 ng/ml), Aleuria
aurantia Lectin (AAL, B-1395, 33 ng/ml), Maackia amurensis Lectin II (MAL II, B-
1265, 67 ng/ml), Sophora japonica Lectin (Vector Laboratories, no longer available,
1 μg/ml). FITC conjugated Peanut agglutinin was purchased from Sigma-Aldrich
(PNA, L7381-2MG, 2 μg/ml).
Flow cytometry. Whole blood flow cytometry assays were used for Figs. 1a, 2,
Supplementary Figs. 1a, 2, 3b, d, e, and 8a. Whole blood was washed first in
phosphate-buffered saline (PBS). Purified RBCs were used for the other flow
cytometry experiments. RBC gating was applied by forward and side scatter gating
of both whole blood and purified RBC flow cytometry experiments (Supplementary
Fig. 9a). Staining with anti-glycophorin A (GPA) confirmed gates contained >99%
RBC (data not shown).
For lectin flow cytometry, approximately 5 × 106 RBC were washed three times in
PBS and incubated for 15min at room temperature in calcium buffer (10mM
HEPES, 150mM NaCl2, 2.5 mM CaCl2, pH 7.4) containing 10% Carbo-Free Blocking
Solution (SP5040, Vector Laboratories) for whole blood flow cytometry or just buffer
alone for purified RBC flow cytometry. Biotinylated lectin staining was carried out at
room temperature in the same buffer as the initial blocking step. PNA-FITC and
other antibody staining were carried out in PBS throughout, without contact with
calcium buffer or Carbo-Free Blocking Solution. Lectin and antibody staining was
carried out for 30min at room temperature, protected from light. Annexin V staining
was carried out according to the manufacturer’s instructions (640945, Biolegend). For
biotinylated lectin staining, cells were then washed and incubated with streptavidin
PE-Cy7 (0.27 µg/ml; 25431782, eBioscience) or PE (0.67 µg/ml; 554061, BD
Pharmingen) for 30min at room temperature. Humanized Fc fusions of murine C-
type lectins17,44 (5 µg/ml) were incubated with RBC for 30min at room temperature
in calcium buffer, then detected by Alexa Fluor 647 goat anti-human secondary
antibody (2 µg/ml; 109-605-098, Jackson ImmunoResearch Laboratories). In tests of
their specificity for binding RBC, lectin or Fc fusion proteins were first incubated with
mannan (5mg/ml, unless otherwise stated) for 15min at room temperature.
Biotinylated BRIC 132 and BRIC 163 (10 µg/ml; 9458B and 9410B, International
Blood Group Reference Laboratory) and anti-O-GlcNAc (1 µg/ml, RL2; 59624, Santa
Cruz) binding to RBC were performed in PBS for 30min at room temperature,
before incubation with streptavidin secondary (for BRIC 132/163) or anti-mouse PE
secondary (for anti-O-GlcNAc) for a further 30min.
Prior to intracellular staining, RBC was fixed with glutaraldehyde (0.05%,
10 min, room temperature), permeabilized with Triton X-100 (0.1% in PBS) for 5
min at room temperature, and then washed in PBS. Cells were washed before
cytometric analysis. Data were acquired on a FACSCalibur (BD) and analyzed
using FlowJo v10.0 (Treestar) software. Normalized geometric mean fluorescences
(gMFI) were calculated by subtracting the gMFI of secondary antibody/
Fig. 4 High mannose decoration of spectrin containing fragments in sickle cell disease. a Galanthus nivalis Agglutinin (GNA) lectin western blot from
healthy (HbAA) and homozygote sickle hemoglobin (HbSS) ghosts. b Above are shown further GNA lectin western blots from HbAA and HBSS ghosts.
The histogram below the blot shows the flow cytometrically measured surface GNA lectin staining values of the RBCs used to make the ghosts, with each
bar corresponding to the cells used to make the western lane above. The r-value to the right of the 100 kDa size label is Spearman’s rank correlation
coefficient between GNA lectin staining values and band intensities, both classified ordinally as high, medium, or low (post hoc analysis p= 1.3 × 10−6, n=
27 measurements from 22 individuals, no statistical adjustment made for other bands). c GNA lectin blot from HbSS ghosts: untreated (U), treated by
PNGase (P) or Endo-H (E). d High exposure β-spectrin blot showing PNGase and partial/full (0.1×/1×) Endo-H digestion of two HbSS ghosts. e Lectin
precipitation of healthy ghosts with GNA or Maackia amurensis Lectin II (MAL-II) lectins. No lectin control is also shown. Immunoblot with the β-spectrin
specific antibody. f Super-resolution microscopy image of spectrin membrane skeleton (blue) from healthy (AA) and sickle cells (SS). Yellow clusters of
GNA staining are overlaid. 3D image is sliced to reveal a single sheet of membrane skeleton network. g GNA lectin blot of spectrin released from HbSS
ghosts after digestion with trypsin for one hour. Untreated (UT), Tx indicates the dilution factor of trypsin relative to spectrin material. h The amino acid
sequence of α-spectrin showing peptide coverage (presence or absence of bar above the line) and intensity (proportional to the height of the bar) from
proteomic analysis of F40 following chymotrypsin treatment. i GNA lectin blots showing Endo-H treatment of the 10 kDa concentrate from e under native
or denaturing conditions (urea/SDS/2-mercaptoethanol) for 24 h. j 3D SIM super-resolution microscopy of surface GNA lectin binding and internal β-
spectrin in HbSS RBC. Cells are first stained with GNA lectin (yellow), then permeabilized, and stained with anti-spectrin antibody (blue) (k).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21814-z ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:1792 | https://doi.org/10.1038/s41467-021-21814-z | www.nature.com/naturecommunications 9
streptavidin-only paired controls. For PNA-FITC and Annexin V analysis,
unstained controls were used for gMFI normalization.
RBC ghost preparation. Washed RBCs were subjected to ice-cold hypotonic lysis
in 20 mM Tris, pH 7.6, with protease inhibitor (05056489001, Roche).45 Lysates
were washed three times in hypotonic lysis buffer (37,000 × g, 4 °C, 30 min) before
resuspension in minimal hypotonic lysis buffer. Protein concentrations were
determined by protein BCA assay (23227, Pierce). No trypsinization was per-
formed before any glycan analysis.
Glycomic mass spectrometry (MS). N-linked glycan analysis from RBC ghosts
was performed according to Jang-Lee et al.46. MS and MS/MS data from the
permethylated purified glycan fractions were acquired on a 4800 MALDI-TOF/
TOF mass spectrometer (Applied Biosystems). Data were processed using Data
Explorer 4.9 Software (Applied Biosystems). The processed spectra were subjected
to manual assignment and annotation with the aid of a glycobioinformatics tool,
GlycoWorkBench.47 Proposed assignments for the selected peaks were based on
12C isotopic composition together with knowledge of the biosynthetic pathways,
and structures were confirmed by data obtained from MS/MS experiments.
Proteomics. RBC ghost membranes were subjected to SDS-PAGE (10% Bis-Tris
gel with MOPS running buffer). SDS-gel bands were excised, sliced into small
pieces, and destained with 200 μl of 1:1 v:v acetonitrile:ammonium bicarbonate
(50 mM, pH 8.4; AMBIC). Destained gel pieces were then reduced by treatment
with 10 mM DTT in AMBIC at 56 °C for 30 min, carboxymethylated in 55 mM
iodoacetic acid in AMBIC in the dark at room temperature, and then subjected to
overnight sequencing grade modified trypsin (Promega V5111) digestion in
AMBIC at 37 °C. After enzyme inactivation (100 °C water bath, 3 min), the
digested peptides were extracted twice from the gel pieces by incubating sequen-
tially (15 min with vortexing) with 0.1% trifluoroacetic acid and 100% acetonitrile.
Finally, the volume was reduced with a SpeedVac. Eluted peptides were analyzed by
LC–MS using a NanoAcquity UPLC™ system coupled to a Synapt™ G2-S mass
a b 
c d 
Fig. 5 High levels of mannose are displayed by sickle cell trait RBCs in response to both oxidative stress and infection with P. falciparum. a Galanthus
nivalis Agglutinin (GNA) lectin binding to healthy (HbAA) (n= 18) versus sickle cell trait (HbAS) (n= 21), compound heterozygotes for hemoglobins S and
C (HbSC) (n= 16), homozygotes for hemoglobin S (HbSS) (n= 14) RBCs in response to oxidative stress, expressed as a ratio to mean of oxidized HbAA
samples. Data are shown as median+/− IQR, 2 tailed Mann–Whitney. p values relative to HbAA: HbSC, p= 8.6 × 10−6, HbSS, p= 3.5 × 10−5. Each data
point indicates an independent RBC donor over more than five independent experiments. b HbS percentage is plotted against elevation of GNA lectin
binding in response to oxidative stress as in a. (****p= 3.5 × 10−7). HbAA, HbAS, and HbSC donor samples are shown as indicated. Spearman’s rank
statistics shown. c) GNA binding to HbAA, HbAS, and HbSS RBCs in response to infection with P. falciparum. Values for rings, trophozoites, and schizonts
are expressed as ratios relative to the uninfected gate. Linked one-way ANOVA analysis for HbAA (p= 0.027), HbAS (p= 9.5 × 105), HbSS (n.s. p=
0.192); Tukey’s multiple comparisons within each genotype. n= 27 independent RBC donors over five independent experiments. Data are shown as
mean+/− SD. d Plot of relative GNA lectin binding for RBCs infected by schizonts against relative PfEMP1 expression. Hemoglobin phenotypes of donors
as indicated, Spearman’s rank.
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spectrometer (Waters MS Technologies, Manchester, UK) in positive ion mode.
Five microliters of the sample was injected onto the analytical column (Waters,
HSS T3, 75 μm× 150mm, 1.8 μm). For the 260kD band, peptides were eluted
according to the following linear gradient program (A: 0.1% v/v formic acid in the
water, B: 0.1% v/v formic acid in acetonitrile): 0–90 min, 3–50% of B. MS data were
acquired on the Synapt G2-S using a data-dependent acquisition program, cali-
brated using Leu-Enkephalin peptide standard. The top 20 components were
selected for MS/MS acquisition. The F40 band was analyzed with MSe with 10–40%
of B. MSe is a feature of the Waters Q-TOF mass spectrometer acquisition control
allowing the alternating generation of total fragment ion data from the ion beam,
switching between high and low collision energies, without the prior individual
mass selection of DDA. Identification of the eluted peptides was performed using
ProteinLynx Global SERVER™ v3.03 (Waters) using a human porcine trypsin
database (Uniprot 1.0). The following were set as workflow parameters on PLGS:
fixed carboxymethyl modification for cysteine, variable deamidation, and oxidation
modifications for glutamine and methionine respectively.
Human monocyte-derived macrophage (HMDM) preparation and culture.
Mononuclear cells were isolated by density centrifugation from whole blood and
seeded at 106 cells/ml in Roswell Park Memorial Institute medium (RPMI (21875-
034, Gibco)), 100 U/ml penicillin, 100 µg/ml streptomycin, 292 µg/ml L-glutamine
(10378-016, Gibco) and 10% heat-inactivated autologous serum. Cultures were
incubated at 37 °C with 5% CO2 for 14–21 days. Cells were washed with RPMI
three times prior to use.
Phagocytosis Assay. For identification of phagocytosis by microscopy, RBC was
stained with Cell Trace Far Red (CTFR) (C34564, Molecular Probes) according to
the manufacturer’s instructions with minor alterations: CTFR was diluted at 1 in
500 (2 μl/ml) in RPMI with penicillin and streptomycin (RPMI/PS) media and
incubated with 20 µl packed RBC for 30 min at 37 °C, after which staining was
inhibited by adding 10% FCS (10270-106, Gibco). Stained cells were washed in
RPMI/PS prior to counting and addition to macrophages. RBC was added to
HMDM at 5 × 107 cells per well for 3 h, before removal of cells, washing, and
fixation with 4% paraformaldehyde (Supplementary Fig. 6a). RBC bound, but not
ingested, by HMDM were then stained with anti-glycophorin-FITC (HIR2 anti-
body; 306610, Biolegend). Cells were imaged using an immunofluorescence
microscope (Zeiss AxioObserver Z1). Phagocytic macrophages were defined as
containing at least one CTFR-positive GPA-FITC-negative RBC (determined by
bright field). Three examples of oxidized RBC phagocytosis are shown in Sup-
plementary Fig. 6b, marked P. RBC-binding macrophages were defined as asso-
ciated with at least one glycophorin-FITC/CTFR double-positive RBC. Analysis of
HMDM phagocytosis included only the small, non-granular subset of macro-
phages, because of consistent association with phagocytosis and binding of RBC.
For quantification of phagocytosis, 200-500 such macrophages were counted per
treatment. To test the specificity of HMDM recognition, the polymers mannan
(10 mg/ml; M-7504, Sigma-Aldrich), chitin (50 μg/ml; C9752, Sigma-Aldrich) or
laminarin (10 mg/ml; L9634, Sigma-Aldrich), or anti-CD206 blocking antibody
(10 µg/ml clone 15.2 321102, BioLegend; isotype control mouse IgG1 kappa clone
107.3; 554721, BD Biosciences) were added to cultures 60 min before phagocytosis
assays. Coumarin-stained 6 µm Fluoresbrite carboxylate microspheres, of similar
size to RBC, were used to assess RBC independent phagocytosis (Supplementary
Fig. 6e).
RBC oxidation and eryptosis. Purified RBC was incubated for 60 or 30 min,
respectively, with 0.2 mM copper sulfate and 5 mM ascorbic acid at 37 °C in
DMEM with 4.5 g/L glucose. Cells were washed in PBS 3 times prior to use. To
induce eryptosis, calcium ionophore (2 µM, A23187, Sigma-Aldrich) was applied at
37 °C in DMEM, with 4.5 g/L glucose, to purified RBC for 3 h.
Reactive Oxygen Species (ROS) production. The rate of ROS production was
determined by first loading purified oxidized or untreated RBC with oxidation
sensitive dye CM-H2DCFDA (10 µM; C6827, Molecular Probes) in PBS and
incubating for 60 min in the dark at 37 °C. RBCs were then washed three times,
resuspended in DMEM and fluorescence determined immediately by spectro-
fluorimeter (Fluostar Optima; BMG Labtech) with excitation of 485 nm and
emission 530 nm. The rate of ROS formation was calculated for the linear portion
of the fluorescence/time curve generated over six hours, which typically lasted for
three hours.
Lectin/Immuno-blotting. Ghost preparations were mixed in equal volumes with
SDS sample buffer containing 8M urea45 and heated at 100 °C for 10 min. Ghost
protein samples were fractionated by gel electrophoresis using NuPage 4–12% Bis-
Tris gel (Invitrogen, NP0312BOX) and transferred by western blotting (30 V, 1 h)
to polyvinylidene fluoride membrane (P 0.45 µm; 10600023 Amersham Hybond,
GE Healthcare). Blots were probed with biotinylated GNA lectin (40 µg/ml; B1245,
Vector Laboratories) and Streptavidin HRP (1:2500 dilution, 3999 S, Cell Signaling)
in a calcium-binding buffer (10 mM HEPES, 150 mM NaCl2, 2.5 mM CaCl2, pH
7.4) containing 1× Carbo-Free Blocking Solution (Vector Laboratories, SP-5040)
and protease inhibitor cocktail (11836145001, Roche) before development in
Amersham ECL Select substrate (RPN2235, GE Healthcare). 0.1% Tween-20 was
added in probing and washing steps. Loading of wells was normalized by protein
concentration (~6 µg per sample). Enzymes PNGase F (P0704S, New England
Biolabs) and Endo-Hf (P0703L, New England Biolabs) were used according to the
manufacturer’s instructions to treat RBC ghost samples prior to electrophoresis.
Lectin precipitation. RBC ghosts were suspended in equal volumes of calcium-
binding buffer containing 2% Triton X-100, pre-cleared with magnetic streptavidin
beads (88816, Pierce), and incubated with biotinylated GNA lectin (1 mg/ml;
B1245, Vector Laboratories), biotinylated MAL-II lectin (1 mg/ml; B1265, Vector
Laboratories) or buffer only overnight at 4 °C. Precipitation with magnetic strep-
tavidin beads was performed in a binding buffer and the beads washed with a
binding buffer containing 0.1% Triton X-100. Washed precipitates were denatured
at 100 °C for 10 min and supernatants loaded for gel electrophoresis and blotting.
Blots were probed with anti-spectrin antibody (1 in 20,000 dilutions; S3396, Sigma-
Aldrich) and anti-mouse-HRP secondary antibody (1 in 10,000 dilutions, 5887,
Abcam). PBS/0.1% Tween 20 replaced calcium-binding buffer for lectin blotting.
Spectrin purification. Spectrin was purified following the method of Ungewickell
et al. with slight modifications.48 Briefly, the ghosts were washed twice and
resuspended in 3 volumes of 37 °C pre-warmed sodium phosphate (0.3 mM, pH
7.2) (extraction buffer) and incubated for 20 min at 37 °C. The fragmented ghosts
were pelleted by centrifugation at 40,000 × g for 1 h at 2 °C. The supernatant was
used as spectrin preparation for analysis.
Serial trypsin dilution treatment of spectrin. Spectrin preparations or ghosts
were analyzed for protein content by BCA assay. Titrations of trypsin at con-
centrations as a fraction of sample concentration were applied for one hour or
longer if indicated, at 37 °C. No trypsin addition was applied to the untreated
sample, which was also incubated for the same duration. Samples were all heat-
inactivated at 100 °C for 10 min, after diluting with 8M urea sample buffer at a
1:1 ratio.
Chymotrypsin and pepsin digestions. Chymotrypsin and pepsin were applied at
1:5 dilution in the sample. Combinatorial protease treatment over 48 h was per-
formed with heat inactivation for 100 °C, 10 min at 24 h. During pepsin treatment,
the sample was pre-diluted 1:1 with HCl, pH2.0. Acid was neutralized with NaOH
after 24 h, prior to the addition of other proteases.
Isolation of trypsin resistant sickle fragment (TRSF)(F40). Approximately
20 ml of HbSS ghosts, having been washed with low cold salt extraction buffer
(0.3 M sodium phosphate, pH 7.6), was treated with 1:5 trypsin: sample ratio
overnight. Heat inactivation at 100°C was carried out for 10 min. The supernatant
was harvested and further centrifuged to remove insoluble products. The clarified
supernatant was subsequently concentrated with a 100 kDa cut-off concentrator
(Pierce, Thermo Fisher, 88533) and supernatant applied to and concentrated with a
10 kDa cut-off concentrator to approximately 500 µl.
Mass spectrometry glycomic analysis of TRSF. Urea containing sample
buffer, as above, was applied to TRSF. Coomassie bands corresponding to the
40–44 kD region were cut and analyzed in three segments: 39–40 kD, 41–42 kD,
and 43–44 kD.
Dual-color western. Amersham western blotting machines were used to detect
GNA lectin and anti-spectrin binding using Cy3 and Cy5 conjugated reagents.
Data were acquired and analyzed by Amersham’s inbuilt software.
Immunofluorescence microscopy. Cell surface GNA lectin binding for immu-
nofluorescence was performed as for flow cytometry with minor alterations (107
cells per test, 8 µg/ml GNA lectin, 1 µg/ml Streptavidin PE. For Fig. 1b and Sup-
plementary Fig.1c and 1d, 8 µg/ml GNA lectin and 1 µg/ml Streptavidin PE were
pre-complexed overnight). Intracellular GNA lectin binding followed fixation
(0.005% glutaraldehyde/PBS, 10 min, room temperature) and permeabilization
(0.1% Triton-X 100/PBS, 15 min, room temperature). Stained cells were pulse
centrifuged (≤300 × g) for 30 s (including acceleration), in 24 well, flat bottom
tissue culture plates (Greiner). To stain CD206, cells were blocked for 15 min with
1% BSA/PBS at room temperature in the dark and incubated with Alexa-488
conjugated anti-mannose receptor antibody (1.25 µg/ml, Clone 19.2; 53-2069-47,
eBiosciences). DAPI (as per manufacturer’s instructions; D1306, Thermo Fisher)
staining was applied to cells post-fixation/permeabilization for 30 min at room
temperature. Cells were washed in PBS and imaged at ×32 magnification using an
immunofluorescence microscope (Zeiss AxioObserver Z1). Images were analyzed
by Zen (Black and Blue versions, Zeiss).
siRNA knockdown of mannose receptor. Human mannose receptor (CD206)
siRNA (UACUGUCGCAGGUAUCAUCCA) or a non-targeting siRNA sequence
control (4390843, Life Technologies) were transfected into HMDM (RNAiMax,
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Life Technologies) (n= 4 donors for all siRNA experiments). Knockdown effi-
ciency was established by determining mannose receptor expression by microscopy
using CD206-Alexa-488 staining (described above) in the small non-granular
macrophage sub-population by merging bright field and mannose receptor fluor-
escence staining. Knockdown efficiency was typically 65–85% (Supplementary
Fig. 6c).
Confocal microscopy for RBCs. For spectrin-GNA lectin double-staining
experiments, permeabilized RBCs were stained with anti-human spectrin antibody
(1 in 50 dilutions; S3396, Sigma Aldrich) concurrently with GNA lectin (8 µg/ml)
in calcium buffer. Alexa Fluor 647 anti-mouse antibody (10 µg/ml; A31571,
Thermo Fisher) was applied in conjunction with streptavidin PE (1 µg/ml; Beck-
man Dickinson) following staining of primary reagents. RBCs were gravity sedi-
mented (30 min at room temperature, in the dark) onto poly-L-lysine (Sigma
Aldrich) treated 8 well chamber slides (LabTek). Images were acquired by a Zeiss
LSM 710 microscope.
3D-Structured Illumination Microscopy (3DSIM). GNA lectin/anti-spectrin
stained RBCs were gravity sedimented onto poly-L-lysine treated chamber slides
(LabTek). 3DSIM images were acquired on an N-SIM (Nikon Instruments, UK)
using a 100 × 1.49NA lens and refractive index-matched immersion oil (Nikon
Instruments). Samples were imaged using a Nikon Plan Apo TIRF objective (NA
1.49, oil immersion) and an Andor DU-897X-5254 camera using 561 and 640 nm
laser lines. Z-step size for Z stacks was set to 0.120 µm, as required by the man-
ufacturer’s software. For each focal plane, 15 images (5 phases, 3 angles) were
captured with the NIS-Elements software. SIM image processing, reconstruction,
and analysis were carried out using the N-SIM module of the NIS-Element
Advanced Research software. Images were checked for artifacts using SIMcheck
software (http://www.micron.ox.ac.uk/software/SIMCheck.php). Images were
reconstructed using NiS Elements software v4.6 (Nikon Instruments, Japan) from a
Z stack comprising ≥1 µm of optical sections. In all SIM image reconstructions, the
Wiener and Apodization filter parameters were kept constant. Reconstructed SIM
images were rendered in 3 dimensions using Imaris (Bitplane). Intracellular GNA
lectin and anti-spectrin staining of healthy RBCs were performed following fixation
and permeabilization. In order to co-localize surface GNA lectin with intracellular
spectrin, HbSS RBCs were stained with GNA lectin/streptavidin-PE staining before,
and anti-spectrin/donkey anti-mouse Alexa 647 after, fixation and
permeabilization.
P. falciparum culture in RBCs of different genotypes and flow cytometry
analysis. P. falciparum IT/FCR3 parasites were cultured at 2% hematocrit in
supplemented RPMI.49 Group O+ erythrocytes (Scottish National Blood Trans-
fusion Service, Edinburgh, Scotland) and RPMI 1640 (Invitrogen, Paisley, UK)
were supplemented with 20 mM glucose (Sigma, Poole, UK), 2 mM glutamine
(Invitrogen), 25 mM HEPES (Lonza, Basel, Switzerland), 25 μg/mL gentamicin
(Lonza) with 10% pooled normal human serum (Scottish National Blood Trans-
fusion Service) adjusted to pH 7·2–7·4 with NaOH (Sigma). Flasks were gassed with
1% O2/3% CO2/96% N2 and incubated at 37 °C. Mature trophozoite-infected
erythrocytes were purified to >90% parasitemia by magnetic separation with a
MACS CS column (Miltenyi Biotec, Germany).50 The purified infected ery-
throcytes were used to infect RBCs of different genotypes with a starting para-
sitemia of approximately 0.5%. RBCs were used within 10 days post-bleed, typically
3–5 days. Cultures were gassed with 1% oxygen, 3% carbon dioxide, and 96%
nitrogen, then incubated at 37 °C for 48–72 h. After one cycle of invasion and
growth, flow cytometry was used to assess parasitemia and parasite maturation,51
as well as GNA lectin-binding and PfEMP1 antibody staining. This method uses
internally controlled flow cytometry analysis to separate uninfected red cells, ring-
stage, trophozoite, and schizont stage parasites within the same culture by FACS
gating using a pair of DNA-binding and RNA-binding dyes (Supplementary
Fig. 9b, c). Hypoxia-induced reduction in parasite invasion and growth was
observed in HbAS red cells, as described by Archer et al.8. However, a range of
parasite stages was available within each culture to allow investigation of high
mannose exposure as parasites matured through the blood-stage cycle.
For flow cytometry, infected erythrocytes in binding buffer (10 mM HEPES,
150 mM NaCl, 2.5 mM CaCl2, pH 7.4) were stained with Vybrant Violet (Thermo
Fisher, V35003, 2.5 μM) and ethidium bromide (Sigma-Aldrich, 46067-50ml-F, 1%
in dH20). Biotinylated GNA lectin staining was performed as described above.
Streptavidin APC was used to detect biotinylated GNA lectin. A BD LSRFortessa
(BD Biosciences) was used for flow cytometry and compensation between channels
was carried out prior to the experiment. Relative GNA lectin binding was
calculated for ring, trophozoite, and schizont gates by dividing the gMFI for each
gate by the value measured in the uninfected RBC gate. PfEMP1 expression was
assessed using a rabbit polyclonal antibody raised against the N-terminal region
(DBLαCIDR didomain) of the predominant PfEMP1 variant expressed in the
culture (ITvar70, also known as AFBR6)52,53. The staining with PfEMP1 antibody
(purified total IgG at 10 µg/ml for 30 mins, followed by APC-conjugated goat anti-
rabbit Alexa 647 (Invitrogen, A21244, 2 µg/ml)) was compared to rabbit IgG
control antibody (10 µg/ml, total IgG from a non-immunized rabbit, followed by
secondary antibody as above). Normalized PfEMP1 gMFI was calculated by
subtracting gMFI for rabbit IgG control antibody staining from that of the PfEMP1
antibody staining. Relative PfEMP1 expression for all samples is expressed as a
percentage of the average HbAA schizont PfeMP1 expression per experiment,
which typically contained three HbAA samples.
Statistical analysis. Most data are treated as non-parametrically distributed and
presented with medians and interquartile ranges, with the exception of Fig. 5c,
where means and standard deviations are shown. Statistical significance was
assessed by either two-tailed Mann–Whitney (non-paired data) or two-tailed
Wilcoxon signed-rank tests (paired data). Multiple comparisons between stages of
RBC infection by P. falciparum were analyzed by ANOVA. All calculations were
implemented in Prism version 5.04 (GraphPad Software). All p-values quoted for
Spearman’s rank correlation are two-tailed.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source data can be accessed at https://osf.io/fv6h5/?view_only=65091838d5bb4229b509f
704a1e0c391 (https://doi.org/10.17605/OSF.IO/FV6H5). The mass spectrometry
proteomics data have been deposited to the ProteomeXchange Consortium via the
PRIDE54 partner repository with the dataset identifier PXD024022. The corresponding
author will reply to inquiries about unprocessed raw data upon reasonable
request. Source data are provided with this paper.
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